Sydue-Cadila To Set Up Rs 100-Cr Unit

The Sydue-Cadila pharmaceutical group is setting up a Rs 100-crore state-of-the-art manufacturing complex at Moraiya near Ahmedabad. Built on an area of 1.8 lakh sq mt, the facility will boast a research and development (R&D) centre of international standard, on which the group plans to invest 7.5 per cent of its turnover. The turnover at present is Rs 370 crore as against Rs 175 crore when the Cadila group was redeployed.

The group also aims to be among the top three pharmaceutical companies by the turn of the century through a multi-pronged strategy. These include focusing on fast-growth segments like cardiovasculars, anti-malarials and immunologicals, strengthening its product portfolio through R&D and entering into alliances with global majors in the field such as Centeon of the USA.

The group already has a global presence in over 31 countries in East Europe, Africa, South-East Asia and Sri Lanka with plans to enter the competitive North and South American markets. In India it has a strong distribution network with nearly 2,000 stockists and 1.25 lakh retailers.

Cadila launched 30 new products last year including Falcigo in alliance with Ke Hua of China for the treatment of the chlorequine-resistant malarial infection known as Falciparum.